Diagnos Laboratorium Utama Tbk. vs WIR ASIA Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp228 (market cap 319B, 124.3K 24h volume), while WIR ASIA Tbk. trades at Rp64 (market cap 752.13B, 52.17M 24h volume). The key difference: WIR ASIA Tbk. is far larger — about 2.4× Diagnos Laboratorium Utama Tbk.'s market cap, and WIR ASIA Tbk. is more actively traded (52.17M versus 124.3K). Which is the better fit depends on your goals.
| DGNS | WIRG | |
|---|---|---|
Market Cap | 319B | 752.13B |
Volume | 124.3K | 52.17M |
Lot | 1.24K | 521.73K |
Turnover | 28.28M | 3.32B |
Average Price | 227.48 | 63.58 |
Value | 28.28M | 3.32B |
Indicative Equilibrium Price | 228 | 64 |
Indicative Equilibrium Volume | 100 | 7.67K |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT WIR ASIA Tbk (the Company) was established on Notarial Deed No. 16 dated August 15, 2011 of Musa Muamarta, S.H. The Company started its commercial operations in 2013.
Read more on WIRG →